English
SPCCT

For an improved detection and monitoring of cardiovascular and neurovascular diseases.

The objective of the SPCCT project is to develop and validate a widely accessible, new quantitative and analytical in vivo imaging technology combining Spectral Photon Counting CT and contrast agents, to accurately and early detect, characterize and monitor neurovascular and cardiovascular disease.

*Video of a 3D volume rendering from an acquisition with the Spectral photon counting CT.

Find out more
SPCCT
Europe

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 668142.

Opening up great prospects for the future of photon counting imaging.

At the interface between medicine, biology and advanced technology, the project involves the Université Claude Bernard Lyon 1, Philips, Mathym, University of Torino, Voxcan, Erasmus University Rotterdam, Cliniques Universitaires St-Luc, Lyon Ingénierie Projets, King's College London, and BRACCO.

From spectral detection CT to photon counting

Find out the testimony of Professors Philippe Douek and Loïc Boussel from Hospices Civils de Lyon on innovations in spectral imaging - from spectral detection to photon counting
title
title
title
title

Our latest news

First in-human
The article “First in-human results of CT angiography for coronary stent assessment with a Spectral Photon-Counting CT” has been recently accepted for publication at “Investigative radiology”.
Vivo coronary stent assessment with SPCCT
Vivo coronary stent assessment with SPCCT

Ce site utilise des cookies pour vous offrir le meilleur service. Vous pouvez cependant choisir de ne pas les utiliser en validant votre choix ci-dessous. Pour en savoir plus sur l'utilisation de cookies sur ce site, vous pouvez cliquer ici.